Fabricio Ferreira de Oliveira, MD, PhD is an expert in Neurology at Federal University of São Paulo (Brazil). As of September 2026, ScienceLeadR ranks Fabricio Ferreira de Oliveira in the top 1% of experts in Brazil for Alzheimer Disease, Dementia and Neurocognitive Disorders. Fabricio Ferreira de Oliveira has authored 85 publications, the most recent in 2026. SLR score: 282 (community average: 125). How the SLR is computed.

LeadR Profile

Fabricio Ferreira de Oliveira, MD, PhD Federal University of São Paulo Brazil
282 ScienceLeadR Reputation 282
Network Map

Neurology

Subspecialties: Psychiatry - Biochemistry - Psychology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1998 - 2026

Source: PubMed

Federal University of São Paulo

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 85

Citations

Citations: 1 262 1st author: 40 Last author: 3 Unique author: 6


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
A world view: Considerations of sociocultural diversity in the study of subjective cognitive decline in Alzheimer's disease and related dementias.
PMID 42683545 — dementia, alzheimer disease, cognitive dysfunction, research
Alzheimers Dement20260
Validated Measures of Agitation in Neurocognitive Disorders: A Systematic Review of 41 Scales and Their Alignment With International Psychogeriatric Association Criteria.
PMID 42425806 — dementia, mental disorders, neurocognitive disorders, cognitive dysfunction, aggression
Am J Geriatr Psychiatry20260
Fluid Biomarkers of Motor and Non-Motor Experiences of Daily Living in Dementia with Lewy Bodies and Alzheimer's Disease.
PMID 41877517 — dementia, lewy bodies, ubiquitin, alzheimer disease, sleep, biomarkers, sex, amyloid, nervous system diseases, synucleins
Can J Neurol Sci20260
International consensus for the assessment of social cognition in neurocognitive disorders: framework definition and clinical recommendations of the SIGNATURE initiative.
PMID 41350737 — alzheimer disease, neurocognitive disorders, social cognition, diagnosis, research, memory, cognition
Alzheimers Res Ther20250
Plasma biomarkers in neuropsychiatric syndromes: A narrative review.
PMID 41284585 — neuropsychiatry, dementia, frontotemporal dementia, alzheimer disease, cognitive dysfunction, biomarkers, signs and symptoms, behavioral symptoms, neurodegenerative diseases, plasma
J Alzheimers Dis20250

LeadR Networks

Main global connection map